CBUS CIBUS INC

Cibus Provides Webcast of BofA Securities AgTech Virtual Conference Fireside Chat

Cibus Provides Webcast of BofA Securities AgTech Virtual Conference Fireside Chat

SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that Peter Beetham, Co-Founder, President and Interim Chief Executive Officer, participated in the BofA Securities 2025 AgTech Virtual Conference this week.

During the fireside chat, hosted by BofA research analyst Stephen Byrne, management discussed the Company's differentiated gene editing platform, the progression of its productivity trait pipeline towards commercial milestones and how the advancements in recent regulatory developments are supporting agricultural innovation in global markets.

The webcast is now available for replay in the events section of the Company's investor relations website at .

About Cibus

Cibus is a leader in gene edited productivity traits that address critical productivity and sustainability challenges for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately $300 billion annually. Cibus is not a seed company. It is a technology company that uses gene editing to develop and license traits to seed companies in exchange for royalties on seed sales. Cibus' long-term focus is productivity traits for farmers for the major global row crops with large acreage such as canola, corn, rice, soybean, and wheat. Cibus is a technology leader in high-throughput gene editing technology that is expected to enable it to develop and commercialize plant traits at a fraction of the time and cost of conventional breeding. Cibus has developed a current pipeline of five productivity traits including important traits for weed management in Rice, Pod Shatter Reduction, and Sclerotinia (disease) resistance, which are its near-term focus.

CIBUS CONTACTS:

INVESTOR RELATIONS

Karen Troeber



858-450-2636

Jeff Sonnek – ICR



MEDIA RELATIONS

Colin Sanford



203-918-4347



EN
27/05/2025

Underlying

CBUSCIBUS INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CIBUS INC

 PRESS RELEASE
Free
CBUS CIBUS INC

Cibus Partnering with The John Innes Centre for UK Government’s Farmin...

Cibus Partnering with The John Innes Centre for UK Government’s Farming Innovation Programme Precision Breeding Initiative Cibus to utilize proprietary Rapid Trait Development System™ to enable development of durable resistance to Light Leaf Spot disease, which has caused estimated yield losses of up to £300m in recent years SAN DIEGO, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced its participation as a key technology partner in...

February 6, 2026 1 EN
 PRESS RELEASE
Free
CBUS CIBUS INC

Cibus, Inc. Announces Pricing of $20.0 Million Public Offering of Clas...

Cibus, Inc. Announces Pricing of $20.0 Million Public Offering of Class A Common Stock SAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced the pricing of an underwritten public offering of 13,333,333 shares of its Class A Common Stock, par value $0.0001 per share (“Class A Common Stock”), at a public offering price of $1.50 per share (the “Offering”). Members of Cibus’ Board of Directors will purchase 1,000,000 shares of Class...

January 29, 2026 1 EN
 PRESS RELEASE
Free
CBUS CIBUS INC

Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock

Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock SAN DIEGO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that it intends to offer shares of its Class A common stock, par value $0.0001 per share (“Class A Common Stock”), in an underwritten public offering (the “Offering”). Cibus also expects to grant to the underwriter of the Offering a 30-day option to purchase up to an additional 15% of the shares of Class A...

January 28, 2026 1 EN
 PRESS RELEASE
Free
CBUS CIBUS INC

Cibus and Interoc Advance Rice Commercialization Strategy for Herbicid...

Cibus and Interoc Advance Rice Commercialization Strategy for Herbicide-Tolerant Traits in Key Markets across Latin America Nonbinding Letter of Intent (LOI) sets framework for potential 2027 market entry in Ecuador and Colombia, followed by expansion into Peru, Central America and the Caribbean Expected to build on success under the existing 2024 material transfer agreement, shifting focus to market execution and revenue generation for co-developed herbicide-tolerant (HT) rice traits SAN DIEGO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technol...

January 5, 2026 1 EN
 PRESS RELEASE
Free
CBUS CIBUS INC

Cibus Welcomes the Positive Conclusion of Trilogue Negotiations on New...

Cibus Welcomes the Positive Conclusion of Trilogue Negotiations on New Genomic Techniques Legislation Between the European Parliament and Council Political agreement on New Genomic Techniques (NGTs), including gene editing, advances a science-based path for plant breeding innovation and supports Cibus’ plans to bring improved traits to European growers The agreed legislative text outlining a framework for NGTs in the EU will now move to formal endorsement by the European Parliament and Council SAN DIEGO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company”), a lea...

December 11, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch